Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, Marianne Shawe‐Taylor, Phoebe Stevenson-Leggett, James Bazire, Rebecca Penn, Ruth Harvey, Crick COVID serology pipeline, Legacy Investigators, Vincenzo Libri, George Kassiotis, Steve J. Gamblin, Nicola S. Lewis, Bryan Williams, Charles Swanton, , Mary Y Wu
The paper evaluates neutralising antibody titres against SARS-CoV-2 variant JN.1 using live-virus microneutralisation assays in vaccinated individuals, finding higher titres in monovalent vaccine recipients.
bioRxiv · Apr 17, 2024 · PreprintMicrobiology